Skip to main content
Skip to search
Skip to main menu
Skip to page specific menu
Skip to footer area
Site Menu
Close
Search the New Ali Lab 2024 site
Search
A-Z
|
Search All UMass Chan Sites
Research
Research
HIV-1 Protease Inhibitors
HCV NS3/4A Protease Inhibitors
Publications
The Lab
The Lab
The PI
Lab Members
Lab Alumni
Lab Culture
Lab News
Collaborators
Contact
Additional Resources
About
Admissions
Education
Faculty
Research
Diversity
Giving
Search
Close Search
Ali Lab
Page Menu
x
New Ali Lab 2024
Home
Research
HIV-1 Protease Inhibitors
HCV NS3/4A Protease Inhibitors
Publications
The Lab
The PI
Lab Members
Lab Alumni
Lab Culture
Lab News
Collaborators
Contact
New Ali Lab 2024
Home
Research
HIV-1 Protease Inhibitors
HCV NS3/4A Protease Inhibitors
Publications
The Lab
The PI
Lab Members
Lab Alumni
Lab Culture
Lab News
Collaborators
Contact
Our most recent publications:
Total:
displaying 10 out of
40
results
Efficient convergent synthesis of 1,3-diazepinone nucleosides by ring-closing metathesis and direct glycosylation
Thursday, November 21, 2024
Author(s):
Adam K Hedger,Jonathan Findell,Dinesh S Barak,Celia A Schiffer,Jonathan K Watts,Akbar Ali
Source:
RSC advances
Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance
Saturday, September 28, 2024
Author(s):
Vincent N Azzolino,Ala M Shaqra,Akbar Ali,Nese Kurt Yilmaz,Celia A Schiffer
Source:
Viruses
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues
Saturday, May 27, 2023
Author(s):
Gordon J Lockbaum,Linah N Rusere,Mina Henes,Klajdi Kosovrasti,Desaboini Nageswara Rao,Ean Spielvogel,Sook-Kyung Lee,Ellen A Nalivaika,Ronald Swanstrom,Nese Kurt Yilmaz,Celia A Schiffer,Akbar Ali
Source:
European journal of medicinal chemistry
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
Wednesday, March 15, 2023
Author(s):
Ean Spielvogel,Sook-Kyung Lee,Shuntai Zhou,Gordon J Lockbaum,Mina Henes,Amy Sondgeroth,Klajdi Kosovrasti,Ellen A Nalivaika,Akbar Ali,Nese Kurt Yilmaz,Celia A Schiffer,Ronald Swanstrom
Source:
eLife
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease
Tuesday, November 29, 2022
Author(s):
Jacqueto Zephyr,Desaboini Nageswara Rao,Colby Johnson,Ala M Shaqra,Ellen A Nalivaika,Aria Jordan,Nese Kurt Yilmaz,Akbar Ali,Celia A Schiffer
Source:
Bioorganic chemistry
Phenylsulfamoyl Benzoic Acid Inhibitor of ERAP2 with a Novel Mode of Inhibition
Wednesday, June 29, 2022
Author(s):
Richa Arya,Zachary Maben,Digamber Rane,Akbar Ali,Lawrence J Stern
Source:
ACS chemical biology
Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance
Sunday, February 20, 2022
Author(s):
Jacqueto Zephyr,Desaboini Nageswara Rao,Sang V Vo,Mina Henes,Klajdi Kosovrasti,Ashley N Matthew,Adam K Hedger,Jennifer Timm,Elise T Chan,Akbar Ali,Nese Kurt Yilmaz,Celia A Schiffer
Source:
Journal of molecular biology
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants
Wednesday, August 18, 2021
Author(s):
Desaboini Nageswara Rao,Jacqueto Zephyr,Mina Henes,Elise T Chan,Ashley N Matthew,Adam K Hedger,Hasahn L Conway,Mohsan Saeed,Alicia Newton,Christos J Petropoulos,Wei Huang,Nese Kurt Yilmaz,Celia A Schiffer,Akbar Ali
Source:
Journal of medicinal chemistry
Inhibiting HTLV-1 Protease: A Viable Antiviral Target
Tuesday, February 23, 2021
Author(s):
Gordon J Lockbaum,Mina Henes,Nathaniel Talledge,Linah N Rusere,Klajdi Kosovrasti,Ellen A Nalivaika,Mohan Somasundaran,Akbar Ali,Louis M Mansky,Nese Kurt Yilmaz,Celia A Schiffer
Source:
ACS chemical biology
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
Thursday, January 28, 2021
Author(s):
Gordon J Lockbaum,Archie C Reyes,Jeong Min Lee,Ronak Tilvawala,Ellen A Nalivaika,Akbar Ali,Nese Kurt Yilmaz,Paul R Thompson,Celia A Schiffer
Source:
Viruses
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond
Thursday, January 07, 2021
Author(s):
Ashley N Matthew,Florian Leidner,Gordon J Lockbaum,Mina Henes,Jacqueto Zephyr,Shurong Hou,Desaboini Nageswara Rao,Jennifer Timm,Linah N Rusere,Debra A Ragland,Janet L Paulsen,Kristina Prachanronarong,Djade I Soumana,Ellen A Nalivaika,Nese Kurt Yilmaz,Akbar Ali,Celia A Schiffer
Source:
Chemical reviews
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere
Friday, July 17, 2020
Author(s):
Linah N Rusere,Gordon J Lockbaum,Mina Henes,Sook-Kyung Lee,Ean Spielvogel,Desaboini Nageswara Rao,Klajdi Kosovrasti,Ellen A Nalivaika,Ronald Swanstrom,Nese Kurt Yilmaz,Celia A Schiffer,Akbar Ali
Source:
Journal of medicinal chemistry
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
Friday, April 03, 2020
Author(s):
Ashley N Matthew,Jacqueto Zephyr,Desaboini Nageswara Rao,Mina Henes,Wasih Kamran,Klajdi Kosovrasti,Adam K Hedger,Gordon J Lockbaum,Jennifer Timm,Akbar Ali,Nese Kurt Yilmaz,Celia A Schiffer
Source:
mBio
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir
Tuesday, December 24, 2019
Author(s):
Jennifer Timm,Klajdi Kosovrasti,Mina Henes,Florian Leidner,Shurong Hou,Akbar Ali,Nese Kurt Yilmaz,Celia A Schiffer
Source:
ACS chemical biology
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope
Wednesday, August 07, 2019
Author(s):
Linah N Rusere,Gordon J Lockbaum,Sook-Kyung Lee,Mina Henes,Klajdi Kosovrasti,Ean Spielvogel,Ellen A Nalivaika,Ronald Swanstrom,Nese Kurt Yilmaz,Celia A Schiffer,Akbar Ali
Source:
Journal of medicinal chemistry
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease
Friday, December 14, 2018
Author(s):
Gordon J Lockbaum,Florian Leidner,Linah N Rusere,Mina Henes,Klajdi Kosovrasti,Gily S Nachum,Ellen A Nalivaika,Akbar Ali,Nese Kurt Yilmaz,Celia A Schiffer
Source:
ACS infectious diseases
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease
Tuesday, August 28, 2018
Author(s):
Ashley N Matthew,Florian Leidner,Alicia Newton,Christos J Petropoulos,Wei Huang,Akbar Ali,Nese KurtYilmaz,Celia A Schiffer
Source:
Structure (London, England : 1993)
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants
Tuesday, July 24, 2018
Author(s):
Linah N Rusere,Ashley N Matthew,Gordon J Lockbaum,Muhammad Jahangir,Alicia Newton,Christos J Petropoulos,Wei Huang,Nese Kurt Yilmaz,Celia A Schiffer,Akbar Ali
Source:
ACS medicinal chemistry letters
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants
Friday, June 09, 2017
Author(s):
Ashley N Matthew,Jacqueto Zephyr,Caitlin J Hill,Muhammad Jahangir,Alicia Newton,Christos J Petropoulos,Wei Huang,Nese Kurt-Yilmaz,Celia A Schiffer,Akbar Ali
Source:
Journal of medicinal chemistry
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side
Friday, March 17, 2017
Author(s):
Kuan-Hung Lin,Akbar Ali,Linah Rusere,Djade I Soumana,Nese Kurt Yilmaz,Celia A Schiffer
Source:
Journal of virology
Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease
Friday, August 12, 2016
Author(s):
Djadé I Soumana,Nese Kurt Yilmaz,Akbar Ali,Kristina L Prachanronarong,Celia A Schiffer
Source:
Journal of the American Chemical Society
P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates
Wednesday, January 06, 2016
Author(s):
Miriam Sansó,Rebecca S Levin,Jesse J Lipp,Vivien Ya-Fan Wang,Ann Katrin Greifenberg,Elizabeth M Quezada,Akbar Ali,Animesh Ghosh,Stéphane Larochelle,Tariq M Rana,Matthias Geyer,Liang Tong,Kevan M Shokat,Robert P Fisher
Source:
Genes & development
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172
Sunday, December 20, 2015
Author(s):
Djadé I Soumana,Nese Kurt Yilmaz,Kristina L Prachanronarong,Cihan Aydin,Akbar Ali,Celia A Schiffer
Source:
ACS chemical biology
Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy
Tuesday, May 12, 2015
Author(s):
Jean Ndjomou,M Josie Corby,Noreena L Sweeney,Alicia M Hanson,Cihan Aydin,Akbar Ali,Celia A Schiffer,Kelin Li,Kevin J Frankowski,Frank J Schoenen,David N Frick
Source:
ACS chemical biology
Structural analysis of asunaprevir resistance in HCV NS3/4A protease
Tuesday, September 23, 2014
Author(s):
Djadé I Soumana,Akbar Ali,Celia A Schiffer
Source:
ACS chemical biology
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance
Tuesday, September 10, 2013
Author(s):
Madhavi N L Nalam,Akbar Ali,G S Kiran Kumar Reddy,Hong Cao,Saima G Anjum,Michael D Altman,Nese Kurt Yilmaz,Bruce Tidor,Tariq M Rana,Celia A Schiffer
Source:
Chemistry & biology
Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance
Friday, April 19, 2013
Author(s):
Akbar Ali,Cihan Aydin,Reinhold Gildemeister,Keith P Romano,Hong Cao,Ayşegül Ozen,Djade Soumana,Alicia Newton,Christos J Petropoulos,Wei Huang,Celia A Schiffer
Source:
ACS chemical biology
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors
Thursday, August 23, 2012
Author(s):
Keith P Romano,Akbar Ali,Cihan Aydin,Djade Soumana,Ayşegül Ozen,Laura M Deveau,Casey Silver,Hong Cao,Alicia Newton,Christos J Petropoulos,Wei Huang,Celia A Schiffer
Source:
PLoS pathogens
Synthesis and structure-activity relationship studies of HIV-1 virion infectivity factor (Vif) inhibitors that block viral replication
Saturday, May 05, 2012
Author(s):
Akbar Ali,Jinhua Wang,Robin S Nathans,Hong Cao,Natalia Sharova,Mario Stevenson,Tariq M Rana
Source:
ChemMedChem
Molecular Basis for Drug Resistance in HIV-1 Protease
Friday, October 14, 2011
Author(s):
Akbar Ali,Rajintha M Bandaranayake,Yufeng Cai,Nancy M King,Madhavi Kolli,Seema Mittal,Jennifer F Murzycki,Madhavi N L Nalam,Ellen A Nalivaika,Ayşegül Özen,Moses M Prabu-Jeyabalan,Kelly Thayer,Celia A Schiffer
Source:
Viruses
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Friday, November 19, 2010
Author(s):
Keith P Romano,Akbar Ali,William E Royer,Celia A Schiffer
Source:
Proceedings of the National Academy of Sciences of the United States of America
P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes
Thursday, June 17, 2010
Author(s):
Siobhan K O'Brien,Hong Cao,Robin Nathans,Akbar Ali,Tariq M Rana
Source:
The Journal of biological chemistry
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance
Friday, March 19, 2010
Author(s):
Madhavi N L Nalam,Akbar Ali,Michael D Altman,G S Kiran Kumar Reddy,Sripriya Chellappan,Visvaldas Kairys,Aysegül Ozen,Hong Cao,Michael K Gilson,Bruce Tidor,Tariq M Rana,Celia A Schiffer
Source:
Journal of virology
Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication
Thursday, July 16, 2009
Author(s):
Akbar Ali,Animesh Ghosh,Robin S Nathans,Natalia Sharova,Siobhan O'Brien,Hong Cao,Mario Stevenson,Tariq M Rana
Source:
Chembiochem : a European journal of chemical biology
Small-molecule inhibition of HIV-1 Vif
Tuesday, September 23, 2008
Author(s):
Robin Nathans,Hong Cao,Natalia Sharova,Akbar Ali,Mark Sharkey,Ruzena Stranska,Mario Stevenson,Tariq M Rana
Source:
Nature biotechnology
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres
Sunday, August 19, 2007
Author(s):
G S Kiran Kumar Reddy,Akbar Ali,Madhavi N L Nalam,Saima Ghafoor Anjum,Hong Cao,Robin S Nathans,Celia A Schiffer,Tariq M Rana
Source:
Journal of medicinal chemistry
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands
Friday, December 08, 2006
Author(s):
Akbar Ali,G S Kiran Kumar Reddy,Hong Cao,Saima Ghafoor Anjum,Madhavi N L Nalam,Celia A Schiffer,Tariq M Rana
Source:
Journal of medicinal chemistry
Dissecting RNA-interference pathway with small molecules
Saturday, June 25, 2005
Author(s):
Ya-Lin Chiu,Chimmanamada U Dinesh,Chia-ying Chu,Akbar Ali,Kirk M Brown,Hong Cao,Tariq M Rana
Source:
Chemistry & biology
Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
Wednesday, August 25, 2004
Author(s):
Ya-Lin Chiu,Akbar Ali,Chia-Ying Chu,Hong Cao,Tariq M Rana
Source:
Chemistry & biology
Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication
Tuesday, July 15, 2003
Author(s):
Seongwoo Hwang,Natarajan Tamilarasu,Karen Kibler,Hong Cao,Akbar Ali,Yueh-Hsin Ping,Kuan-Teh Jeang,Tariq M Rana
Source:
The Journal of biological chemistry
Back To Top ▲
